These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1803 related items for PubMed ID: 8625307

  • 41. Resistance of human breast-cancer cells to the pure steroidal anti-estrogen ICI 182,780 is not associated with a general loss of estrogen-receptor expression or lack of estrogen responsiveness.
    Larsen SS, Madsen MW, Jensen BL, Lykkesfeldt AE.
    Int J Cancer; 1997 Sep 17; 72(6):1129-36. PubMed ID: 9378550
    [Abstract] [Full Text] [Related]

  • 42. Association of interferon regulatory factor-1, nucleophosmin, nuclear factor-kappaB, and cyclic AMP response element binding with acquired resistance to Faslodex (ICI 182,780).
    Gu Z, Lee RY, Skaar TC, Bouker KB, Welch JN, Lu J, Liu A, Zhu Y, Davis N, Leonessa F, Brünner N, Wang Y, Clarke R.
    Cancer Res; 2002 Jun 15; 62(12):3428-37. PubMed ID: 12067985
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Resveratrol acts as an estrogen receptor (ER) agonist in breast cancer cells stably transfected with ER alpha.
    Levenson AS, Gehm BD, Pearce ST, Horiguchi J, Simons LA, Ward JE, Jameson JL, Jordan VC.
    Int J Cancer; 2003 May 01; 104(5):587-96. PubMed ID: 12594813
    [Abstract] [Full Text] [Related]

  • 45. Inhibition of estrogen receptor alpha expression and function in MCF-7 cells by kaempferol.
    Hung H.
    J Cell Physiol; 2004 Feb 01; 198(2):197-208. PubMed ID: 14603522
    [Abstract] [Full Text] [Related]

  • 46. Bimodal regulation of epidermal growth factor receptor by estrogen in breast cancer cells.
    Yarden RI, Lauber AH, El-Ashry D, Chrysogelos SA.
    Endocrinology; 1996 Jul 01; 137(7):2739-47. PubMed ID: 8770893
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Expression of human estrogen receptor using an efficient adenoviral gene delivery system is able to restore hormone-dependent features to estrogen receptor-negative breast carcinoma cells.
    Lazennec G, Katzenellenbogen BS.
    Mol Cell Endocrinol; 1999 Mar 25; 149(1-2):93-105. PubMed ID: 10375022
    [Abstract] [Full Text] [Related]

  • 49. The carboxy-terminal F domain of the human estrogen receptor: role in the transcriptional activity of the receptor and the effectiveness of antiestrogens as estrogen antagonists.
    Montano MM, Müller V, Trobaugh A, Katzenellenbogen BS.
    Mol Endocrinol; 1995 Jul 25; 9(7):814-25. PubMed ID: 7476965
    [Abstract] [Full Text] [Related]

  • 50. WISP-2 gene in human breast cancer: estrogen and progesterone inducible expression and regulation of tumor cell proliferation.
    Banerjee S, Saxena N, Sengupta K, Tawfik O, Mayo MS, Banerjee SK.
    Neoplasia; 2003 Jul 25; 5(1):63-73. PubMed ID: 12659671
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. The normal epithelial cell-specific 1 (NES1) gene is up-regulated by steroid hormones in the breast carcinoma cell line BT-474.
    Luo LY, Grass L, Diamandis EP.
    Anticancer Res; 2000 Jul 25; 20(2A):981-6. PubMed ID: 10810385
    [Abstract] [Full Text] [Related]

  • 53. c-Myc overexpression and endocrine resistance in breast cancer.
    McNeil CM, Sergio CM, Anderson LR, Inman CK, Eggleton SA, Murphy NC, Millar EK, Crea P, Kench JG, Alles MC, Gardiner-Garden M, Ormandy CJ, Butt AJ, Henshall SM, Musgrove EA, Sutherland RL.
    J Steroid Biochem Mol Biol; 2006 Dec 25; 102(1-5):147-55. PubMed ID: 17052904
    [Abstract] [Full Text] [Related]

  • 54. Stable transfection of protein kinase C alpha cDNA in hormone-dependent breast cancer cell lines.
    Tonetti DA, Chisamore MJ, Grdina W, Schurz H, Jordan VC.
    Br J Cancer; 2000 Sep 25; 83(6):782-91. PubMed ID: 10952784
    [Abstract] [Full Text] [Related]

  • 55. Insulin-like growth factor binding protein 2 is a marker for antiestrogen resistant human breast cancer cell lines but is not a major growth regulator.
    Juncker-Jensen A, Lykkesfeldt AE, Worm J, Ralfkiaer U, Espelund U, Jepsen JS.
    Growth Horm IGF Res; 2006 Aug 25; 16(4):224-39. PubMed ID: 16893667
    [Abstract] [Full Text] [Related]

  • 56. Modulation of estrogen receptor mRNA expression by melatonin in MCF-7 human breast cancer cells.
    Molis TM, Spriggs LL, Hill SM.
    Mol Endocrinol; 1994 Dec 25; 8(12):1681-90. PubMed ID: 7708056
    [Abstract] [Full Text] [Related]

  • 57. Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor.
    Osborne CK, Coronado EB, Kitten LJ, Arteaga CI, Fuqua SA, Ramasharma K, Marshall M, Li CH.
    Mol Endocrinol; 1989 Nov 25; 3(11):1701-9. PubMed ID: 2558302
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Expression and regulation of estrogen receptor beta in human breast tumors and cell lines.
    Vladusic EA, Hornby AE, Guerra-Vladusic FK, Lakins J, Lupu R.
    Oncol Rep; 2000 Nov 25; 7(1):157-67. PubMed ID: 10601611
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 91.